Hello X! We are a #microbiology company developing new #preclinical models for #antimicrobial discovery and #diagnostics. Please visit synthbiome.com for more information.

We are open for business! We offer a number of highly validated preclinical models to study Cystic Fibrosis pathogens, including SCFM2 (pnas.org/doi/10.1073/pn…). For more information, please contact [email protected].

Exciting news! Introducing our new preclinical model for studying Cystic Fibrosis infection, SCFM4! SCFM4 was developed by SynthBiome for the discovery of #Pseudomonas aeruginosa #bacteriophage for treatment of CF lung infections. Ready to learn more? Contact

Elevate your CF research with our premium Synthetic Cystic Fibrosis Models (SCFM)! Precise conditions, reproducible results, & enhanced outcomes. Quality assured & competitively priced. Contact us today! #CysticFibrosis #SCFM #BiomedicalResearch #Innovation #Healthcare #Research

Resistance to #Antibiotics is a growing concern. SynthBiome is enhancing our toolkit to fight #AMR by enabling #DrugDiscovery in patient-like conditions, e.g. SCFM2 for #CysticFibrosis lung infections. Read more: doi.org/10.1038/s41564…